ERBA Diagnostics, Inc. 8-K 2013
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
November 6, 2013
(Date of earliest event reported)
ERBA Diagnostics, Inc.
(Exact name of registrant as specified in its charter)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
(b) On September 10, 2013, ERBA Diagnostics, Inc. (the “Company”), filed a Current Report on Form 8-K announcing the results of its 2013 Annual Meeting of the Stockholders (the “Annual Meeting”), which was held on September 10, 2013. At the Annual Meeting, the Company’s stockholders made a non-binding advisory vote that the Company should hold future advisory votes on Named Executive Officer compensation, commonly known as “say-on-frequency,” every three years.
(d) This Current Report on Form 8-K is filed to amend the above described Current Report on Form 8-K. On November 6, 2013, the Company’s Board of Directors (the “Board”) held a regularly scheduled meeting at which time the Board unanimously approved the “say-on-frequency” favored by the Company’s stockholders, and, as such, the Company will include a stockholder vote on Named Executive Officer compensation in its proxy materials every three years.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.